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Abstract
Background: We report a new case of small bowel metastases from primary lung cancer. Such
metastases are not exceptional, but their clinical manifestations are rare.
Case presentation: The case involved a 56-year-old man with a squamous cell carcinoma of the
lung (stage IV) that had been treated with chemotherapy. He presented fourteen months after
diagnosis with an acute abdominal pain. Abdominal CT-scan demonstrated a perforated jejunum
and he underwent emergency surgery. Postoperative pathologic analysis confirmed the diagnosis
of metastatic pulmonary carcinoma. The patient was discharged after ten days, but died 8 weeks
after surgery at home on tumor progression.
Conclusion: We were able to find 58 documented similar cases in the literature. Most cases
presented with bowel perforation or obstruction. Squamous cell carcinoma was the most common
histological cell type followed by large cell carcinoma. Other metastases are often present, and the
prognosis is mostly fatal at short term.
Background
Lung cancer is the most common cause of cancer related
death in both men and women in Western countries.
More than 25% of all cancer deaths are attributable to
lung cancer [1,2]. Intraabdominal metastases are not
exceptional, but their clinical manifestations are rare [3].
We report such a case presenting with small bowel
perforation.
Case Report
A 56-year-old man (varnisher by profession, heavy
smoker with 160 pack years) presented in September
2002 with a five month history of cough, fever, night-
sweat and a weight loss of 5 kg in 12 months. A bronchos-
copy with biopsy revealed a squamous cell carcinoma of
the lung. A FDG-PET/CT scanning showed a disseminated
praetracheal, aortoal, supraclavicular and infracarinal
lymphadenopathy and a spleen metastasis (stage IV) [4].
The patient received six cycles of Cisplatinum-Gemcitab-
ine chemotherapy, followed by a second line Mitomycine-
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Vinorelbine polychemotherapy. A re-evaluation after one
year revealed liver metastases and increasing mediastinal
lymphadenopathy, followed by additionally Taxotere
polychemotherapy. A brain magnetic resonance imaging
after a pathologically Romberg Test in December 2003
showed a left hemisphere brain metastasis.
At New Year's Day 2004, the patient presented again with
a three days history of increasing abdominal pain, diffuse
abdominal guarding and rebound tenderness. Laboratory
evaluation was without pathological findings except a
marked leukocytosis (WBC = 24,000/mm3).
Abdominal CT-scan displayed free intraperitoneal air and
a perforated jejunum (Figure 1). The patient was operated
on with the diagnosis of perforated jejunum. At surgery, a
2 cm mass was found at the surface of a loop of the jeju-
num with perforation of 1 cm in diameter, furthermore
left upper quadrant peritonitis with pus, stool and a fibrin
coating. The affected segment of the jejunum was resected
with an end-to-end anastomosis and an abdominal lavage
was performed. Postoperative pathologic analysis con-
firmed the diagnosis of metastatic pulmonary carcinoma
(Figure 2). The surgical margins were negative for tumor.
Postoperatively, the patient was given a regular diet on
postoperative day four and discharged home fourteen
days after surgery. The patient died 8 weeks after surgery at
home on tumor progression.
Conclusion and review of the literature
Despite the early and widespread dissemination of lung
carcinoma to many body sites, clinically significant metas-
CT scan with intravenouse contrast: Free intraperitoneal air and a enlarged jejunum Figure 1
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tases in the small bowel are rare and typically occur only
in the advanced stage of the disease [5]. But metastases to
the gastrointestinal tract from lung cancer may not be as
rare as thought according to autopsy series.
Antler et al. report in an autopsy series of 423 cases of pri-
mary tumors of the lung gastrointestinal tract involve-
ment in 58 cases (14%) [6]. Out of these 58 cases, 14 were
caused by direct extension of the tumor from the lung. 44
cases (10%) had distant metastasis without contact of the
primary tumor to the gastrointestinal tract. The most com-
mon site of metastasis was the oesophagus (29 cases), fol-
lowed by ileum (13 cases) and stomach (10 cases).
Mc Neill et al. reported in their autopsy study of 431 cases
small/large bowel metastases without oesophageal/stom-
ach metastases in 46 cases (11%) [7]. All patients with
small bowel metastasis had at least one other site of met-
astatic disease with an average of 4.8 sites.
In an autopsy study of Burbige et al. 18 out of 147 (12%)
patients with a diagnosis of primary carcinoma of the lung
had metastatic lesions in the gastrointestinal tract [8].
Twelve of the 18 patients (67%) had signs or symptoms
suggesting gastrointestinal involvement but only four
were diagnosed premortem [8].
Mc Neill et al. and Antler et al. [6,7] report in their autopsy
studies, the most common histologic type of lung tumor
causing gastrointestinal tract metastasis was squamous
cell, followed by large cell carcinoma as shown in Table 1.
In all three autopsy studies large cell carcinoma is relative
to the tumor incidence prone to small bowel metastasis
[6-8].
Reviewing the literature between 1961 and 2003 we were
able to document 58 clinically manifest metastasis to the
small bowel [3,7,9-37]. One report even describes eleven
cases in a thirteen year period in a single institution. This
result strongly suggests that metastasis to the small bowel
may not be as rare as thought.
Over 80% of patients with metastases to the small bowel
were male, with ages ranging from 36 to 78 years with a
median of 60 years.
Metastases to the small bowel may present as perforation
(34/58; 59%), obstruction (17/58; 29%), six (10%)
patients had haemorrhage, and in one patient (2%) the
small bowel metastasis was discovered in a staging CT
scan.
Of those patients with known location of metastasis (n =
38), 21 (55%) had jejunal metastasis, 12 (32%) ileal,
three (8%) duodenal and two (5%) patient had both jeju-
nal and ileal metastasis.
In 34 patients we were able to document the histological
tumor type. Squamous cell carcinoma was the most com-
mon histological cell type (17/34; 50%) followed by large
cell carcinoma (8/34; 24%) and adenocarcinoma (7/34;
21%).
In 7 (12%) patients the initial diagnose of lung cancer was
discovered because of the abdominal symptoms, before
any pulmonary disease was considered. Five out of these
seven patients presented with abdominal perforation.
This fact could retract the statement that particularly
chemotherapy induces necrosis of the tumor cells which
has replaced a portion of the small bowel wall, thus caus-
ing perforation of abdominal metastasis [21,23]. Accord-
ing to McNeill et al. lung cancer metastasis have a greater
tendency to undergo necrosis compared with other malig-
nant tumor metastasis [7]. Therefore, there may be a
greater tendency for these metastases to cause perforation
before attaining enough bulk to cause obstruction [7].
Phillips et al. [38] reviewed the literature for indications
for laparotomy in 27 patients presenting with isolated
small bowel metastases from extra-abdominal primary
sites in a 22 year time period. The author found only six
small bowel perforations and all six were in patients with
carcinomas of the lung as primary site.
Table 1: Incidence of cell type causing gastrointestinal (Antler et al.) or small/large bowel (McNeill et al.) metastases
Histologic cell type Antler et al. 1982 [6]: 58 gastrointesinal 
metastasis out of 423 cases
McNeill et al. 1987 [7]: 46 small/large bowel 
metastasis out of 431 cases
Squamous cell 19 out of 173 (11%) 15/5 out of 199 (10%)
Adenocarcinoma 6 out of 72 (8%) 13/6 out of 108 (18%)
Large cell 17 out of 87 (20%) 12/6 out of 31 (58%)
Small Cell 11 out of 48 (23%) 6/5 out of 73 (15%)
Others 5 out of 43 (11%) 0/2 out of 20 (10%)International Seminars in Surgical Oncology 2005, 2:13 http://www.issoonline.com/content/2/1/13
Page 4 of 5
(page number not for citation purposes)
Small bowel metastasis typically occurs in the final states
of widespread disease [7].
Surgery in this group of patients will have a high morbid-
ity and mortality due to cancer, age and associated medi-
cal problems [36]. Of those patients who were known to
have died (n = 39), mean postoperative survival was 3
weeks. Nine (9/39; 23%) patients died within the first
week, 25 (25/39; 64%) within the first month, four
patients however were alive more than one year after
surgery.
Review of the literature indicates that metastases of pri-
mary pulmonary carcinoma to small bowel occur late in
the course of the disease, are more common than thought
and may be associated with serious clinical complica-
tions. When symptomatic, patients usually present with a
small bowel perforation, obstruction or haemorrhage.
Squamous cell carcinoma and large cell carcinoma of the
lung are more likely to result in gastrointestinal metas-
tases than the other cell types.
Treatment of obstructed or perforated small bowel is sim-
ilar to any acute surgical abdomen: prompt exploratory
laparotomy. When perforation of small bowel lesions is
found, the procedure of choice is resection of the involved
small intestine with primary enteroenterostomy, obstruc-
tions could be treated with bypass procedures.
Small bowel metastasis; Stain: Hematoxylin & Eosin (amplification 1:62) Figure 2
Small bowel metastasis; Stain: Hematoxylin & Eosin (amplification 1:62).Publish with BioMed Central    and   every 
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